Literature DB >> 27033630

Cyclophilin A: A Key Factor in Virus Replication and Potential Target for Anti-viral Therapy.

Farman Ullah Dawar1, Jiagang Tu, Muhammad Nasir Khan Khattak, Jie Mei, Li Lin.   

Abstract

Cyclophilin A (CypA) is a key member of immunophilins that has peptidyl-prolyl cis/trans isomerase (PPIase) activity. Besides acting as a cellular receptor for immunosuppressive drug cyclosporine A (CsA), CypA is involved in various cellular activities. CypA has an important role in viral infection which either facilitates or inhibits their replication. Inhibition of CypA via inhibitors is useful for overcoming several viral infections, indicating that CypA is an attractive target for anti-viral therapy. Collectively, these facts demonstrate the critical roles of CypA in mediating or inhibiting viral infections, suggesting that CypA can be an attractive cellular target for the development of anti-viral therapy.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27033630     DOI: 10.21775/cimb.021.001

Source DB:  PubMed          Journal:  Curr Issues Mol Biol        ISSN: 1467-3037            Impact factor:   2.081


  27 in total

1.  The Dengue Virus Nonstructural Protein 1 (NS1) Is Secreted from Mosquito Cells in Association with the Intracellular Cholesterol Transporter Chaperone Caveolin Complex.

Authors:  Romel Rosales Ramirez; Juan E Ludert
Journal:  J Virol       Date:  2019-02-05       Impact factor: 5.103

2.  Exploitation of the Leishmania exosomal pathway by Leishmania RNA virus 1.

Authors:  Vanessa Diniz Atayde; Alonso da Silva Lira Filho; Visnu Chaparro; Aude Zimmermann; Caroline Martel; Maritza Jaramillo; Martin Olivier
Journal:  Nat Microbiol       Date:  2019-01-28       Impact factor: 17.745

Review 3.  Current understanding on molecular drug targets and emerging treatment strategy for novel coronavirus-19.

Authors:  Khadga Raj; Karamjeet Kaur; G D Gupta; Shamsher Singh
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2021-05-07       Impact factor: 3.000

4.  Cyclophilin A Inhibits Human Respiratory Syncytial Virus (RSV) Replication by Binding to RSV-N through Its PPIase Activity.

Authors:  Wenzhang Liang; Yue Zhang; Miao Li; Fadhl Al-Shaebi; Jian Li; Jing Zhang; Lin Wei
Journal:  J Virol       Date:  2021-07-12       Impact factor: 5.103

5.  Chemotactic Activity of Cyclophilin A in the Skin Mucus of Yellow Catfish (Pelteobagrus fulvidraco) and Its Active Site for Chemotaxis.

Authors:  Farman Ullah Dawar; Jiagang Tu; Yang Xiong; Jiangfeng Lan; Xing Xing Dong; Xiaoling Liu; Muhammad Nasir Khan Khattak; Jie Mei; Li Lin
Journal:  Int J Mol Sci       Date:  2016-08-29       Impact factor: 5.923

6.  Cyclophilin J PPIase Inhibitors Derived from 2,3-Quinoxaline-6 Amine Exhibit Antitumor Activity.

Authors:  Xuemei Zhao; Chengcai Xia; Xiaodan Wang; Hao Wang; Ming Xin; Long Yu; Yulong Liang
Journal:  Front Pharmacol       Date:  2018-02-21       Impact factor: 5.810

Review 7.  An Overview of Hepatitis B Virus Surface Antigen Secretion Inhibitors.

Authors:  Alireza Mohebbi; Nazanin Lorestani; Alireza Tahamtan; Niki L Kargar; Alijan Tabarraei
Journal:  Front Microbiol       Date:  2018-04-05       Impact factor: 5.640

Review 8.  Lessons Learned to Date on COVID-19 Hyperinflammatory Syndrome: Considerations for Interventions to Mitigate SARS-CoV-2 Viral Infection and Detrimental Hyperinflammation.

Authors:  Marco Cardone; Masahide Yano; Amy S Rosenberg; Montserrat Puig
Journal:  Front Immunol       Date:  2020-05-29       Impact factor: 7.561

Review 9.  Structural and Functional Insights into Human Nuclear Cyclophilins.

Authors:  Caroline Rajiv; Tara L Davis
Journal:  Biomolecules       Date:  2018-12-04

10.  Human MxB Inhibits the Replication of Hepatitis C Virus.

Authors:  Dong-Rong Yi; Ni An; Zhen-Long Liu; Feng-Wen Xu; Kavita Raniga; Quan-Jie Li; Rui Zhou; Jing Wang; Yong-Xin Zhang; Jin-Ming Zhou; Lei-Liang Zhang; Jing An; Cheng-Feng Qin; Fei Guo; Xiao-Yu Li; Chen Liang; Shan Cen
Journal:  J Virol       Date:  2018-12-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.